Rheumnow Podcast cover image

ACR24 -Day3b

Rheumnow Podcast

00:00

Intro

This chapter explores key abstracts from ACR 2024, including the benefits of apremilast for axial inflammation and encouraging results from the TAC279 trial. It also discusses new diagnostic criteria and screening methods for psoriatic arthritis, reflecting progress in treatment and understanding of the condition.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app